Key Facts Surrounding This News Item
- COLL had a POWR Rating of B (Buy) coming into today.
- COLL was 0.78% above its 10-Day Moving Average coming into today.
- COLL was 2.81% above its 20-Day Moving Average coming into today.
- COLL was 11.35% above its 50-Day Moving Average coming into today.
- COLL was 35.87% above its 100-Day Moving Average coming into today.
- COLL was 70.40% above its 200-Day Moving Average coming into today.
- COLL had returned +34.18% year-to-date leading up to today’s news, versus a +2.26% return from the benchmark S&P 500 during the same period.
More Info About Collegium Pharmaceutical, Inc. (COLL)
Collegium Pharmaceuticals is a specialty pharmaceutical company focused on developing a portfolio of products that incorporate its patent-protected DETERx technology platform for the treatment of chronic pain and other diseases. The company was founded in 2002 and is based in Canton, Massachusetts. View our full COLL ticker page with ratings, news, and more.
Try StockNews.com Premium Today!
Get access to our daily newsletters, Best Stocks List, POWR Ratings, and much more!
Free for 14 days -- no credit card required!